CEL-SCI - Health Technology Insights

CEL-SCI Partners With Saudi Pharma for Cancer Drug Multikine

July 15, 2025

Strong interest from Saudi investment funds in CEL-SCI, Multikine, and potential joint venture to address the wider Middle East and North Africa market CEL-SCI Corporation

CEL-SCI’s Multikine Cancer Drug May Launch in Saudi Arabia by 2025

May 21, 2025

Saudi Food and Drug Authority typically responds to Breakthrough Medicine Designation applications within approximately 60 days CEL-SCI Corporation announced it has completed its Breakthrough Medicine Designation

Categories

Tag: CEL-SCI

CEL-SCI Partners With Saudi Pharma for Cancer Drug Multikine

CEL-SCI’s Multikine Cancer Drug May Launch in Saudi Arabia by 2025

Share With

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup 26 August 2025

Corewell, Quest Partner to Expand Lab Services in Michigan

Acadia Names Konstantina Katcheves as Senior VP

Pulse Biosciences Shares First Human Data on Thyroid Nodule Treatment

Verasonics, ImFusion Partner to Advance Clinical Ultrasound

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands